Search clinical trials for: 15-093

Total 7316 results

Memorial Sloan Kettering Cancer Center

Active, not recruiting

Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer

High Risk for Developing Breast Cancer

United States
Five Eleven Pharma, Inc.
Indiana University

Active, not recruiting

Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer

Prostate Cancer | Prostate Cancer Recurrent

United States
Merrimack Pharmaceuticals

Completed

Safety and Efficacy Study of MM-093 in Patients With Chronic Plaque Psoriasis

Psoriasis

United States
Peking Union Medical College Hospital

Not yet recruiting

68Ga-P16-093 PET/CT Imaging in the Salivary Gland

Primary Sjögren Syndrome
Peking Union Medical College Hospital

Recruiting

68Ga-P16-093 PET/CT Imaging in Glioma Patients

Glioma

China
Five Eleven Pharma, Inc.

Active, not recruiting

Preliminary Evaluation of Uptake of [68Ga]P16-093 in Metastatic Prostate and Renal Cancer

Prostate Cancer | Renal Cancer

United States
Bial - Portela C S.A.

Completed

Pharmacokinetics, Efficacy and Tolerability of BIA 2-093

Epilepsy

Romania
Bial - Portela C S.A.

Completed

A Placebo-controlled Study to Investigate Safety and Efficacy of BIA 2-093

Epilepsy

Portugal
Merrimack Pharmaceuticals

Completed

Phase 2 Study of MM-093 to Treat Patients With Uveitis

Uveitis

United States
Bial - Portela C S.A.

Completed

The Effect of BIA 2-093 on the Steady-state Pharmacokinetics of Digoxin

Epilepsy

Portugal
Bial - Portela C S.A.

Completed

The Tolerability and Effect of Food on the Pharmacokinetics of a Single 800 mg Oral Dose of BIA 2-093

Epilepsy
University of Pennsylvania

Completed

Long-term Follow-up of Subjects Exposed to Lentiviral-based CART-EGFRvIII Gene-modified Cellular Therapy Products in Cancer Studies

Subjects Entering Into This Protocol Will be Followed for up to 15 Years After Initial CART-EGFRvIII Infusion

United States
Bial - Portela C S.A.

Completed

Single-dose and Steady-state Pharmacokinetics of BIA 2-093 and Its Metabolites

Epilepsy

Germany
Bial - Portela C S.A.

Terminated

The Effect of BIA 2-093 on the Steady-state Pharmacokinetic Profile of Phenytoin in Patients

Epilepsy

Portugal
Peking Union Medical College Hospital

Recruiting

68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer Patients

Prostate Cancer

China
Peking Union Medical College Hospital

Recruiting

68Ga PET/CT Imaging in Breast Cancer Patients

Breast Cancer

China
Peking Union Medical College Hospital

Recruiting

68Ga-P16-093 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients

Prostate Cancer

China
Johns Hopkins Bloomberg School of Public Health
Bill and Melinda Gates Foundation; Hopkins Population Center's Mellon Grant; The...

Completed

A Comparison of Survey Methodologies to Elicit Sensitive Information From Adolescents in Urban India

Unmarried Male and Female Adolescents in the Age Group 15-19 Years in Pre-Identified Slums in Delhi, India
Bial - Portela C S.A.

Completed

Eslicarbazepine Acetate (BIA 2-093) as Monotherapy in Patients With Newly Diagnosed Partial-onset Seizures

Epilepsy
Bial - Portela C S.A.

Completed

A Single Centre, Phase I, Double-blind, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetic Profile and Effects on EEG of Single Rising Oral Doses of BIA 2-093

Epilepsy

United Kingdom
Bial - Portela C S.A.

Completed

A Double-blind, Randomised, Placebo-controlled, Rising Multiple Dose Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic Profile and CNS Effects of BIA 2-093

Epilepsy

United Kingdom
Memorial Sloan Kettering Cancer Center
New York Presbyterian Hospital; Rockefeller University

Completed

Improving Therapeutic Outcomes in the Tongue Carcinoma Patient: Assessment of Adaptation Using Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging

Tongue Carcinoma

United States
Mayo Clinic

Completed

Electrophysiological Study of the Effects of Limb Cooling on Essential Tremor

Tremor

United States
Peking Union Medical College Hospital

Completed

68Ga-P16-093 and 18F-FDG PET/CT Imaging in the Same Group of Clear Cell Renal Cell Carcinoma Patients

Clear Cell Renal Cell Carcinoma

China
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); The City College of New York; DOWNSTATE MED/KINGS... and other collaborators

Active, not recruiting

Risk Factors for Endometrial Cancer in Black Women

Endometrial Cancer

United States
University Hospital, Strasbourg, France

Completed

Validation of a Pediatric Pictorial Version of the QOR-15 Postoperatory Functional Recovery Scale - QoR-15 Pédiatric

Surgical Intervention | Minor

France
Saglik Bilimleri Universitesi Gulhane Tip Fakultesi

Completed

Turkish Version of the Postoperative QoR-15 (QoR-15T)

Surgery | Recovery of Function | Postoperative Period | Cross-Cultural Comparison

Turkey
Memorial Sloan Kettering Cancer Center
Samus Therapeutics, Inc.

Completed

PU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Bial - Portela C S.A.

Completed

Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy Volunteers

Epilepsy

Portugal
Bial - Portela C S.A.

Terminated

Eslicarbazepine Acetate as Therapy in Diabetic Neuropathic Pain

Painful Diabetic Neuropathy

Portugal
Memorial Sloan Kettering Cancer Center
Center for Marital and Sexual Health of South Florida

Recruiting

Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery

Erectile Dysfunction | Prostate Cancer

United States
Bial - Portela C S.A.

Completed

Efficacy and Safety of Eslicarbazepine Acetate as Therapy in Subjects With Fibromyalgia

Fibromyalgia
Organon and Co

Completed

Analgesic Treatment Mediated by Arcoxia (0663-093)

Pain
University of Oxford
University of Basel; ClinSearch; Fundação de Medicina Tropical Dr. Heitor Vieira... and other collaborators

Not yet recruiting

Evaluating Pediatric Ivermectin in Children Under 15 kg (EPIC-15) (EPIC-15)

Scabies

Brazil
Bial - Portela C S.A.

Completed

Efficacy, Safety, and Tolerability of Eslicarbazepine Acetate in the Recurrence Prevention of Bipolar I Disorder

Bipolar I Disorder
Memorial Sloan Kettering Cancer Center

Active, not recruiting

BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder

Bladder Cancer | Non-Muscle-Invasive Urothelial Carcinoma

United States
Amgen

Completed

A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease

Celiac Disease

Finland
National Cancer Institute (NCI)

Completed

Continuous Infusion of rhIL-15 for Adults With Advanced Cancer

Lymphoma | Carcinoma

United States
University Hospital, Ghent

Completed

Comparison of Acute Toxicity and Cost Between Whole Breast Irradiation With Sequential Boost and Simultaneous Integrated Boost After Breast Conserving Surgery. (SeqB vs SIB)

Radiotherapy After Breast Conserving Surgery

Belgium
Hospital Ruber Internacional
Zogenix, Inc.

Recruiting

Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes (FENDEEP)

Refractory Epilepsy | STXBP1 Encephalopathy With Epilepsy | SYNGAP1 Encephalopathy | Inv Dup(15) Encephalopathy | Multifocal or Bilateral Malformations of Cortical Development | Continuous Spike and Waves During Slow Sleep

Spain
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Meclofenamate in Subjects With Recurrent or Progressive Brain Metastasis From Solid Tumor Primary

Recurrent Brain Metastases | Progressive Brain Metastases

United States
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University

Completed

Body Composition and White Adipose Tissue Inflammation

Breast Cancer | Body Composition | Prostate Cancer | White Adipose Tissue Inflammation

United States
Dr. Reddy's Laboratories Limited

Completed

Bioavailability of DFN-15 at 3 Different Doses vs. Comparator and to Determine Dose-proportionality of DFN-15 in Fasting Healthy Adults

Healthy

United States
Dr. Reddy's Laboratories Limited

Completed

Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches

Migraine

United States
National Cancer Institute (NCI)

Completed

Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer

Head and Neck Squamous Cell Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Renal Cell Carcinoma | Recurrent Skin Carcinoma | Stage III Renal Cell Cancer | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Non-Small Cell Lung Carcinoma | Stage IIIC Cutaneous Melanoma AJCC v7 | Stage IV... and other conditions

United States
Bial - Portela C S.A.

Completed

Eslicarbazepine Acetate as Add-On Treatment to One Baseline Antiepileptic Drug (ESLADOBA)

Epilepsy

Portugal
Merrimack Pharmaceuticals

Completed

A Phase 2 Study to Evaluate the Efficacy and Safety of 60mg of MM-093 in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Memorial Sloan Kettering Cancer Center
University of Pittsburgh; National Institutes of Health (NIH); Weill Medical...

Recruiting

Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer

Pancreatic Cancer | Benign Pancreatic Disease

United States
Memorial Sloan Kettering Cancer Center
Genentech, Inc.

Completed

Single-agent Cobimetinib for Adults With Histiocytic Disorders

Histiocytic Disorders

United States
University of Zurich

Completed

Visa-versa! Breaking Instead of Pushing the Pedals-D

Healthy (Controls)

Switzerland

Search clinical trials for: 15-093

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations